You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for Patent: 8,420,656


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,420,656
Title:Substituted 5-fluoro-1H-pyrazolopyridines and their use
Abstract: The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Inventor(s): Follmann; Markus (Wulfrath, DE), Stasch; Johannes-Peter (Solingen, DE), Redlich; Gorden (Bochum, DE), Ackerstaff; Jens (Dusseldorf, DE), Griebenow; Nils (Dormagen, DE), Kroh; Walter (Wuppertal, DE), Knorr; Andreas (Erkrath, DE), Becker; Eva-Maria (Wuppertal, DE), Wunder; Frank (Wuppertal, DE), Li; Volkhart Min-Jian (Velbert, DE), Hartmann; Elke (Wuppertal, DE), Mittendorf; Joachim (Wuppertal, DE), Schlemmer; Karl-Heinz (Wuppertal, DE), Jautelat; Rolf (Haan, DE), Bierer; Donald (Haan, DE)
Assignee: Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:13/111,856
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 8,420,656

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Merck Sharp Dohme VERQUVO vericiguat TABLET;ORAL 214377-001 Jan 19, 2021 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
Merck Sharp Dohme VERQUVO vericiguat TABLET;ORAL 214377-002 Jan 19, 2021 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
Merck Sharp Dohme VERQUVO vericiguat TABLET;ORAL 214377-003 Jan 19, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,420,656

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2010 021637May 26, 2010

International Family Members for US Patent 8,420,656

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 081628 ⤷  Try a Trial
Australia 2011257335 ⤷  Try a Trial
Australia 2011257336 ⤷  Try a Trial
Brazil 112012030010 ⤷  Try a Trial
Brazil 122020023470 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.